title: Application of proteomics for the identification of biomarkers in amniotic fluid: are we ready to provide a reliable prediction?
abstract: Proteomics-based identification of biomarkers for fetal abnormalities and pregnancy complications in amniotic fluid (AF) has made significant progress in the past 5 years. This is attributed mainly to advances in mass spectrometry-based proteomic technologies that enable new strategies for discovering biomarkers from complex biological fluids in a high-throughput and sensitive manner. These markers, although they still need to be verified, are diagnostic and may in the future provide targets for therapeutic intervention. In the current review we focus on the emergence of proteomics as a major platform technology in studying AF and developing biomarkers for fetal aneuploidies and pregnancy-related disorders.
authors.affiliation: Proteomics Research Unit, Center of Basic Research II, Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece.
authors.forename: George Th
authors.initials: GT
authors.lastname: Tsangaris
authors.forename: Athanasios K
authors.initials: AK
authors.lastname: Anagnostopoulos
authors.forename: Georgia
authors.initials: G
authors.lastname: Tounta
authors.forename: Aris
authors.initials: A
authors.lastname: Antsaklis
authors.forename: Ariadni
authors.initials: A
authors.lastname: Mavrou
authors.forename: Aggeliki
authors.initials: A
authors.lastname: Kolialexi